PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |infection |
| Sentences | 1297 |
| PubMedID- 21339644 | During infection with the hepatitis a virus (hav), most patients develop mild or asymptomatic disease. |
| PubMedID- 24386416 | infection with hepatitis b (hbv) and/or hepatitis c (hcv) viruses and elevated alcohol consumption are the leading risk factors for hcc . |
| PubMedID- 22453133 | The incidence of acquired immune deficiency syndrome (aids)-defining events has continuously declined over the past years and liver diseases, mainly due to co-infection with the hepatitis c virus (hcv) and/or hepatitis b virus (hbv) or presence of metabolic syndrome-associated non-alcoholic steatohepatitis have emerged as key issues within the hiv infected population 2. |
| PubMedID- 24822056 | Most interestingly from a integrative perspective, the study determined genetic variants, associated to population-specific dna methylation, to be enriched for snps previously identified as risk loci for the infection with the hepatitis b virus (hbv). |
| PubMedID- 23469281 | The main findings of this study on 272 hiv-infected patients in a rural tanzanian setting were a high prevalence of co-infection with viral hepatitis b and that a rapid diagnostic test for hbsag is accurate and precise for screening for hbsag in our setting. |
| PubMedID- 22355450 | infection with hepatitis c virus (hcv) causes chronic disease in approximately 80% of cases, resulting in chronic inflammation and cirrhosis. |
| PubMedID- 26083843 | Moreover, this syndrome may be a first sign of infection with epstein-barr virus, hepatitis b virus, hiv or other viral infections. |
| PubMedID- 22911697 | in addition to traditional ckd risk factors such as diabetes and hypertension, co-infection with hepatitis c virus (hcv) has been suggested as a possible risk factor for ckd in hiv-positive individuals. |
| PubMedID- 24348810 | In the developing world, viral infections are predominant, with hepatitis e infection recognized as a common cause of mortality in many countries (5–8). |
| PubMedID- 21994698 | infection with hepatitis c virus (hcv) continues to be a major global health problem. |
| PubMedID- 20460924 | infection with hepatitis c virus (hcv) primarily causes chronic liver disease with characteristic histopathologic features, including hepatic steatosis. |
| PubMedID- 20827411 | Purpose: although infection with hepatitis c virus (hcv) affects 32 million individuals from southeast asia, little is known about the mode of hcv acquisition and the epidemiology of chronic hepatitis c (chc) in these individuals. |
| PubMedID- 21726511 | Background & aims: chronic infection with hepatitis b or c virus (hbv or hcv) is a leading cause of cirrhosis by unknown mechanisms of pathogenesis. |
| PubMedID- 24589829 | infection with hepatitis b or c virus is the major risk factor for liver cancer, which accounts for more than 85% of cases in developing countries. |
| PubMedID- 24069230 | Exclusion criteria included: infection with hepatitis b or c; an aids defining condition within 42 days of baseline; having received any immunomodulatory agents/vaccine within 60 days or any blood products within 6 months of screening. |
| PubMedID- 25979354 | infection of hepatocytes with hepatitis c virus led to the incorporation and export of viral genomic and sub-genomic rna sequences in evs. |
| PubMedID- 22914343 | High rates of infection with hepatitis a and b viruses, diphtheria, and influenza have been reported in homeless people.12 furthermore, a narrative review by raoult and colleagues12 has shown the morbidity associated with foot problems and skin infections—eg, scabies, body lice, and louse-transmitted infections. |
| PubMedID- 24175062 | Chronic infection with hepatitis c virus (hcv) is treated with a combined therapy of peginterferon-α-2a (pegifn-α-2a) or pegifn-α-2b and ribavirin. |
| PubMedID- 25899746 | Chronic infection with hepatitis b virus (hbv) plays an important role in the etiology of hepatocellular carcinoma (hcc). |
| PubMedID- 22235271 | Covariates that were potential confounders of the relationship between host genetic or pharmacological factors and viral suppression were considered for inclusion in the analysis: demographic-related factors (age, gender), patient-related factors (body mass index, current intravenous drug use, co-infection with hepatitis b or c as defined below), condition-related factors (time living with hiv, time on art, cd4 cell count), and treatment related-factors (prior mono or dual therapy, prior exposure to art, duration of viral suppression prior to study period, nucleoside backbone, co-medications). |
| PubMedID- 22898798 | Liver disease associated to persistent infection with the hepatitis b virus (hbv) continues to be a major health problem of global impact. |
| PubMedID- 23010773 | Introduction: adverse effects appearing during combined peg-interferon and ribavirin antiviral treatment against chronic infection with the hepatitis c virus are a major cause for treatment failures and abrupt interruption. |
| PubMedID- 21569429 | Indeed, the main risk factors for the development of hcc among the chinese population are the presence of liver cirrhosis and chronic infection with hepatitis b virus 4. |
| PubMedID- 23271667 | In addition to its high frequency of metastasis, hepatocellular carcinoma recurrence is characterized by multicentric carcinogenesis arising in the liver damaged by viral infection with the hepatitis b or hepatitis c virus. |
| PubMedID- 21712515 | Systemic coxiella-like infection with myocarditis and hepatitis in an eclectus parrot (eclectus roratus). |
| PubMedID- 25884472 | Most cases of hcc are attributed to chronic infection with either hepatitis b or c virus 2. |
| PubMedID- 23098744 | infection with hepatitis b virus (hbv) continues to be a major global cause of acute and chronic liver disease with high mortality. |
| PubMedID- 20111599 | Exclusion criteria included chronic medical conditions, clinically significant abnormal laboratory parameters, infection with hepatitis b or c, infection with syphilis, or recent receipt of a vaccine or blood transfusion. |
| PubMedID- 20941334 | A possible infection with hepatitis b , and c , , hiv , and syphilis , must also be considered, although these incidents are very rare. |
| PubMedID- 23855159 | hepatitis resulting from viral infection is common worldwide and is associated with significant morbidity and mortality. |
| PubMedID- 24397793 | We also tested these same individuals for anti-hbv-core-antibody (anti-hbc), which indicates past or current infection with the hepatitis b virus, and for anti-hcv antibody, which indicates current infection with the hepatitis c virus. |
| PubMedID- 24114816 | Background and rationale: chronic infection with the hepatitis c virus (hcv) is associated with a higher prevalence of insulin resistance compared to the general population. |
| PubMedID- 22068163 | Objective: to examine recent trends of acute infection with hepatitis b virus (hbv) in japan by nationwide surveillance and phylogenetic analyses. |
| PubMedID- 22548835 | Information regarding duration of the disease, co-infection with hepatitis, previous drug abuse and medication were collected (see table1). |
| PubMedID- 23239466 | infection with hepatitis e virus in kidney transplant recipients in southeastern france. |
| PubMedID- 24898543 | Introduction: infection with the hepatitis c virus (hcv) is the leading cause of chronic hepatitis in patients on hemodialysis. |
| PubMedID- 26183704 | infection with hepatitis c is an important contributor to mortality and morbidity among people living with hiv, primarily due to an increased risk of liver disease . |
| PubMedID- 23861838 | Univariate linear regression analysis identified the following variables as predictors of efavirenz plasma level at week 4; cyp2b6*6 genotype (9.8%, p<0.0001), country (4.8%, p<0.0001), co infection with hepatitis b at recruitment (0.6%, p = 0.061), cyp3a5*1 genotype (1.5%, p = 0.019), abcb1 c.3435c>t (0.8%, p = 0.082), abcb1 c.4036a>g (2.4%, p = 0.003), slco1b1*1b (0.8%, p = 0.084). |
| PubMedID- 22087137 | infection with hepatitis b virus and hepatitis c virus is a major risk factor for hcc in developed countries. |
| PubMedID- 23274669 | Chronic infection with hepatitis b virus (hbv) is associated with impairment of t and nk cell immunity. |
| PubMedID- 24466045 | After infection with hepatitis viruses, some individuals are able to clear the infection, whereas others remain infected and manifest chronic liver inflammation . |
| PubMedID- 22710347 | Targeting mitochondria in the infection strategy of the hepatitis c virus. |
| PubMedID- 20974315 | Background: the standard treatments for chronic infection with the hepatitis c virus (hcv) are peginterferon alpha-2a or alpha-2b plus ribavirin, but it remains unclear if one has a better efficacy and safety profile. |
| PubMedID- 25544499 | infection with hepatitis c virus (hcv), a major viral cause of chronic liver disease, frequently progresses to steatosis and cirrhosis, which can lead to hepatocellular carcinoma. |
| PubMedID- 26539193 | Likewise, murine infection with neurotropic strains of mouse hepatitis virus can also lead to inflammatory demyelination (56). |
| PubMedID- 23933401 | Background and aims: infection with the hepatitis c virus (hvc) is one of the most common viral infections worldwide. |
| PubMedID- 21086945 | A 33-year-old man with human immunodeficiency virus type1 (hiv-1) infection was admitted because of acute hepatitis b. |
| PubMedID- 23469142 | Some studies showed that il28b genotypes were not associated with recovery from hbv infection, clearance of hbeag and hbsag, hepatitis activity and liver cirrhosis , , while other studies showed significant correlations between il28b genotypes and hbv viral load, hepatic inflammation and risk of hcc , . |
| PubMedID- 26367131 | Using a mouse viral fh model by infection with murine hepatitis virus strain-3 (mhv-3), we observed a significant macrophage induction and the serum and liver massive accumulation of il-1β. |
| PubMedID- 24594856 | Chronic infection with hepatitis b virus (hbv) affects 350 to 400 million individuals worldwide and is the leading cause of liver cirrhosis and hepatocellular carcinoma worldwide 1. |